Literature DB >> 33621214

SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities.

Arturo Casadevall1, Jeffrey P Henderson2, Michael J Joyner3, Liise-Anne Pirofski4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33621214      PMCID: PMC8011895          DOI: 10.1172/JCI148832

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  9 in total

1.  Palivizumab-resistant human respiratory syncytial virus infection in infancy.

Authors:  Ortwin Adams; Linda Bonzel; Alexander Kovacevic; Ertan Mayatepek; Thomas Hoehn; Markus Vogel
Journal:  Clin Infect Dis       Date:  2010-07-15       Impact factor: 9.079

2.  SARS-CoV-2 Viral Variants-Tackling a Moving Target.

Authors:  John R Mascola; Barney S Graham; Anthony S Fauci
Journal:  JAMA       Date:  2021-04-06       Impact factor: 56.272

3.  Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment.

Authors:  A Kossyvakis; A-F A Mentis; K Tryfinopoulou; V Pogka; A Kalliaropoulos; E Antalis; T Lytras; A Meijer; S Tsiodras; P Karakitsos; A F Mentis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-15       Impact factor: 3.267

4.  In vivo selection of respiratory syncytial viruses resistant to palivizumab.

Authors:  Xiaodong Zhao; Wayne M Sullender
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Respiratory syncytial virus escape mutant derived in vitro resists palivizumab prophylaxis in cotton rats.

Authors:  Xiaodong Zhao; Fu-Ping Chen; Wayne M Sullender
Journal:  Virology       Date:  2004-01-20       Impact factor: 3.616

6.  SARS-CoV-2 evolution during treatment of chronic infection.

Authors:  Steven A Kemp; Dami A Collier; Rawlings P Datir; Isabella A T M Ferreira; Salma Gayed; Aminu Jahun; Myra Hosmillo; Chloe Rees-Spear; Petra Mlcochova; Ines Ushiro Lumb; David J Roberts; Anita Chandra; Nigel Temperton; Katherine Sharrocks; Elizabeth Blane; Yorgo Modis; Kendra E Leigh; John A G Briggs; Marit J van Gils; Kenneth G C Smith; John R Bradley; Chris Smith; Rainer Doffinger; Lourdes Ceron-Gutierrez; Gabriela Barcenas-Morales; David D Pollock; Richard A Goldstein; Anna Smielewska; Jordan P Skittrall; Theodore Gouliouris; Ian G Goodfellow; Effrossyni Gkrania-Klotsas; Christopher J R Illingworth; Laura E McCoy; Ravindra K Gupta
Journal:  Nature       Date:  2021-02-05       Impact factor: 69.504

7.  REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.

Authors:  David M Weinreich; Sumathi Sivapalasingam; Thomas Norton; Shazia Ali; Haitao Gao; Rafia Bhore; Bret J Musser; Yuhwen Soo; Diana Rofail; Joseph Im; Christina Perry; Cynthia Pan; Romana Hosain; Adnan Mahmood; John D Davis; Kenneth C Turner; Andrea T Hooper; Jennifer D Hamilton; Alina Baum; Christos A Kyratsous; Yunji Kim; Amanda Cook; Wendy Kampman; Anita Kohli; Yessica Sachdeva; Ximena Graber; Bari Kowal; Thomas DiCioccio; Neil Stahl; Leah Lipsich; Ned Braunstein; Gary Herman; George D Yancopoulos
Journal:  N Engl J Med       Date:  2020-12-17       Impact factor: 91.245

8.  Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies.

Authors:  Alina Baum; Benjamin O Fulton; Elzbieta Wloga; Richard Copin; Kristen E Pascal; Vincenzo Russo; Stephanie Giordano; Kathryn Lanza; Nicole Negron; Min Ni; Yi Wei; Gurinder S Atwal; Andrew J Murphy; Neil Stahl; George D Yancopoulos; Christos A Kyratsous
Journal:  Science       Date:  2020-06-15       Impact factor: 47.728

9.  Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant.

Authors:  Leonid Yurkovetskiy; Xue Wang; Kristen E Pascal; Christopher Tomkins-Tinch; Thomas P Nyalile; Yetao Wang; Alina Baum; William E Diehl; Ann Dauphin; Claudia Carbone; Kristen Veinotte; Shawn B Egri; Stephen F Schaffner; Jacob E Lemieux; James B Munro; Ashique Rafique; Abhi Barve; Pardis C Sabeti; Christos A Kyratsous; Natalya V Dudkina; Kuang Shen; Jeremy Luban
Journal:  Cell       Date:  2020-09-15       Impact factor: 66.850

  9 in total
  18 in total

1.  International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary.

Authors:  Arwa Z Al-Riyami; Thierry Burnouf; Mark Yazer; Darrell Triulzi; Levent Tufan Kumaş; Levent Sağdur; Nil Banu Pelit; Renée Bazin; Salwa I Hindawi; Maha A Badawi; Gopal K Patidar; Hem Chandra Pandey; Rahul Chaurasia; Roberta Maria Fachini; Patrícia Scuracchio; Silvano Wendel; Ai Leen Ang; Kiat Hoe Ong; Pampee Young; Jarkko Ihalainen; Antti Vierikko; Yan Qiu; Ru Yang; Hua Xu; Naomi Rahimi-Levene; Eilat Shinar; Marina Izak; Carlos Alberto Gonzalez; David Martin Ferrari; Paula Verónica Cini; Robby Nur Aditya; Ratti Ram Sharma; Suchet Sachdev; Rekha Hans; Divjot Singh Lamba; Lise Sofie H Nissen-Meyer; Dana V Devine; Cheuk Kwong Lee; Jennifer Nga-Sze Leung; Ivan Fan Ngai Hung; Pierre Tiberghien; Pierre Gallian; Pascal Morel; Khuloud Al Maamari; Zaid Al-Hinai; Hans Vrielink; Cynthia So-Osman; Vincenzo De Angelis; Pierluigi Berti; Angelo Ostuni; Giuseppe Marano; Michel Toungouz Nevessignsky; Magdy El Ekiaby; James Daly; Veronica Hoad; Sinyoung Kim; Karin van den Berg; Marion Vermeulen; Tanya Nadia Glatt; Richard Schäfer; Rita Reik; Richard Gammon; Melissa Lopez; Lise Estcourt; Sheila MacLennan; David Roberts; Vernon Louw; Nancy Dunbar
Journal:  Vox Sang       Date:  2021-05-20       Impact factor: 2.996

Review 2.  Use of convalescent plasma in COVID-19 patients with immunosuppression.

Authors:  Jonathon W Senefeld; Stephen A Klassen; Shane K Ford; Katherine A Senese; Chad C Wiggins; Bruce C Bostrom; Michael A Thompson; Sarah E Baker; Wayne T Nicholson; Patrick W Johnson; Rickey E Carter; Jeffrey P Henderson; William R Hartman; Liise-Anne Pirofski; R Scott Wright; De Lisa Fairweather; Katelyn A Bruno; Nigel S Paneth; Arturo Casadevall; Michael J Joyner
Journal:  Transfusion       Date:  2021-06-01       Impact factor: 3.337

3.  Analysis of Immune Escape Variants from Antibody-Based Therapeutics against COVID-19: A Systematic Review.

Authors:  Daniele Focosi; Fabrizio Maggi; Massimo Franchini; Scott McConnell; Arturo Casadevall
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

4.  Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection.

Authors:  Shmuel Shoham; Evan M Bloch; Arturo Casadevall; Daniel Hanley; Bryan Lau; Kelly Gebo; Edward Cachay; Seble G Kassaye; James H Paxton; Jonathan Gerber; Adam C Levine; Judith Currier; Bela Patel; Elizabeth S Allen; Shweta Anjan; Lawrence Appel; Sheriza Baksh; Paul W Blair; Anthony Bowen; Patrick Broderick; Christopher A Caputo; Valerie Cluzet; Marie Elena Cordisco; Daniel Cruser; Stephan Ehrhardt; Donald Forthal; Yuriko Fukuta; Amy L Gawad; Thomas Gniadek; Jean Hammel; Moises A Huaman; Douglas A Jabs; Anne Jedlicka; Nicky Karlen; Sabra Klein; Oliver Laeyendecker; Karen Lane; Nichol McBee; Barry Meisenberg; Christian Merlo; Giselle Mosnaim; Han-Sol Park; Andrew Pekosz; Joann Petrini; William Rausch; David M Shade; Janna R Shapiro; J Robinson Singleton; Catherine Sutcliffe; David L Thomas; Anusha Yarava; Martin Zand; Jonathan M Zenilman; Aaron A R Tobian; David Sullivan
Journal:  medRxiv       Date:  2021-12-14

5.  SARS-CoV-2 Seroprevalence Among Whole Blood Donors During First Wave of Covid-19 Pandemic in India.

Authors:  Srinivasa Rao Chunchu; Ushasree Ravula; Vikram Kumar Gente; Srinivas Bacchu; S Pandu Ranga Rao; Srujaleswari Mooli
Journal:  Indian J Hematol Blood Transfus       Date:  2022-01-30       Impact factor: 0.915

Review 6.  Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?

Authors:  Xuesong He; Xiao Xue Zeng
Journal:  Drug Des Devel Ther       Date:  2022-03-30       Impact factor: 4.162

Review 7.  Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.

Authors:  Stephen A Klassen; Jonathon W Senefeld; Katherine A Senese; Patrick W Johnson; Chad C Wiggins; Sarah E Baker; Noud van Helmond; Katelyn A Bruno; Liise-Anne Pirofski; Shmuel Shoham; Brenda J Grossman; Jeffrey P Henderson; R Scott Wright; DeLisa Fairweather; Nigel S Paneth; Rickey E Carter; Arturo Casadevall; Michael J Joyner
Journal:  Front Med (Lausanne)       Date:  2021-06-07

Review 8.  Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.

Authors:  Uttpal Anand; Shweta Jakhmola; Omkar Indari; Hem Chandra Jha; Zhe-Sheng Chen; Vijay Tripathi; José M Pérez de la Lastra
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

9.  Persistence of functional memory B cells recognizing SARS-CoV-2 variants despite loss of specific IgG.

Authors:  Stephan Winklmeier; Katharina Eisenhut; Damla Taskin; Heike Rübsamen; Ramona Gerhards; Celine Schneider; Paul R Wratil; Marcel Stern; Peter Eichhorn; Oliver T Keppler; Matthias Klein; Simone Mader; Tania Kümpfel; Edgar Meinl
Journal:  iScience       Date:  2021-12-20

Review 10.  Is there a place for mesenchymal stromal cell-based therapies in the therapeutic armamentarium against COVID-19?

Authors:  Patricia Rieken Macêdo Rocco; Bruno Solano de Freitas Souza; Kátia Nunes da Silva; André Luiz Nunes Gobatto; Zaquer Suzana Munhoz Costa-Ferro; Bruno Raphael Ribeiro Cavalcante; Alex Cleber Improta Caria; Luciana Souza de Aragão França; Carolina Kymie Vasques Nonaka; Fernanda de Macêdo Lima; Miquéias Lopes-Pacheco
Journal:  Stem Cell Res Ther       Date:  2021-07-27       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.